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Outcome of a comprehensive follow-up program
to enhance maturation of autogenous
arteriovenous hemodialysis access
Robert B. McLafferty, MD, Raymond W. Pryor III, MD, Colleen M. Johnson, MD,
Don E. Ramsey, MD, and Kim J. Hodgson, MD, Springfield, Ill
Objective: To examine the outcome of a comprehensive follow-up program for autogenous arteriovenous hemodialysis
access (AVF) when performed by the hemodialysis access surgeon.
Methods: Patients with first time AVFs between 2000 and 2005 underwent history and physical examination between the
third and sixth postoperative weeks, followed by repeat examination every 6 to 8 weeks until maturation. Primary
outcomes included maturation assessment and interventions required prior to maturation. Maturation was defined as 4
consecutive weeks of sustainable AVF hemodialysis access.
Results: One hundred thirteen patients had 113 AVFs. Mean age was 64 years (range: 26-94) and 52% were male. AVFs
included 8 (7%) radiocephalic, 90 (80%) brachiocephalic, and 15 (13%) basilic vein transposition. Overall, the maturation
rate was 72% (failure rate of 28%). Excluding deaths and transplants prior to maturation, the maturation rate was 82%
(failure rate 18%). Eighty-three (73%) patients had no intervention prior to maturation and 30 (27%) required
intervention. There was no significant difference in failure rate between AVFs not requiring an intervention (13 of 83,
15%) and those requiring intervention (5 of 30, 16%). For AVFs requiring intervention, 23 (61%) patients had an
endovascular intervention and 15 (39%) an operative intervention. One intervention was performed in 64%, two in 24%,
and three in 12%. Ninety-three percent of AVFs having an endovascular intervention matured compared with 60% having
operative intervention (P .10). AVFs requiring intervention had amaturation time (mean: 35 weeks, range: 10-54) that
was significantly longer (P  .003) than those without (mean 11 weeks, range: 6-35).
Conclusions:With a surgeon directed comprehensive follow-up program to assess AVFmaturation, a large proportion (30
of 43, 69%) of AVFs with a problem were detected. Of those identified, most (25 of 30, 83%) could be salvaged to
maturation with intervention. The Kidney and Dialysis Outcome Quality Initiative (K/DOQI) should consider
incorporating a comprehensive follow-up program into its guidelines. ( J Vasc Surg 2007;45:981-5.)The Kidney Disease Outcome Quality Initiative (K/
DOQI) represents a comprehensive consensus statement
using evidence based methods to provide guidelines to
optimize care of patients with chronic and end-stage renal
disease (ESRD). First published in 1997 and revised in
2001, K/DOQI recommends that autogenous arterio-
venous hemodialysis access (AVF) make up at least 50% of
all new permanent hemodialysis access operations.1,2 Of
the 38 clinical practice guidelines for vascular access, guide-
line 9 addresses the topic of optimizing AVF maturation.
Specific recommendations are made regarding optimal di-
ameter and time for cannulation; direct methods to en-
hance maturation such as hand exercises and obliteration of
side branches; and resting the AVF after needle infiltration.
There are no recommendations concerning optimal rou-
tine follow-up after AVF creation to examine for specific
signs of maturation failure.
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doi:10.1016/j.jvs.2007.01.013The mandate of K/DOQI and other programs such as
Fistula First have had success in increasing the numbers of
AVFs performed in the United States.3-6 Nevertheless,
failure rates due to lack of maturation continue to be a
major obstacle with reports ranging from 25% to 43%.
Herein, the outcome of a comprehensive follow-up and
intervention program specifically performed by the surgeon
following AVF creation is examined.
METHODS
The operative and endovascular procedure database
(PATS, Inc. Seattle, Wash) prospectively maintained by the
Division of Vascular Surgery at Southern Illinois University
was queried for all first time AVFs in patients already on
hemodialysis from July 2000 to June 2005 performed by
the primary author (R.B.M.). Following patient identifica-
tion, a retrospective review was conducted. Patients with
AVF placed prior to needing hemodialysis were not in-
cluded in the study. AVF was defined as radiocephalic,
brachiocephalic, and basilic vein transposition. All basilic
vein transpositions were one stage operations. Charts were
retrospectively reviewed for basic demographic informa-
tion, risk factors, AVF interventions prior to maturation,
and maturation time. Maturation of AVF was defined as
sustainable hemodialysis access 4 consecutive weeks with
two needle access and acceptable flow rates (400-600 ml/
min).
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for permanent hemodialysis access was performed in the
outpatient vascular surgery clinic. In determining whether
permanent hemodialysis access could be performed in the
arm, evaluation included history and physical examination
and selected preoperative vascular laboratory studies such
as finger plethysmography in patients with hand neuropa-
thy or absent wrist pulses and duplex examination of jugu-
lar/subclavian veins for suspicion of occlusion. All patients
underwent preoperative arm vein duplex mapping without
tourniquet the same day of surgery. Scanning protocol
included determining cephalic and basilic vein diameter as
well as vein continuity. The largest continuous arm vein was
utilized for creation of an AVF, generally regardless of
handedness. An arteriovenous graft was placed if the ma-
jority of the cephalic or basilic vein lengths were less than
2.5 mm in diameter. Similarly, an arteriovenous graft was
placed in morbidly obese patients with only an adequate
basilic vein.
All patients undergoing an AVF were followed in the
outpatient vascular surgery clinic. The first postoperative
visit was between 3 and 6 weeks for examination, suture
removal, and patient education. Follow-up ensued every
6 to 8 weeks until the patient was on dialysis using two
needles with adequate flow (400-600 ml/min) for 1
month. At each interval of follow-up, the patients under-
went directed physical examination for signs of impend-
ing thrombosis or lack of maturation. Such signs in-
cluded the development of a hammer pulse in the
proximal AVF, minimal thrill with low flow suspected,
minimal increase in vein dilatation, increasing number of
branches visualized, increasing arm edema, barely audi-
ble or highly pitched bruit, problems with needle cannu-
lation due to AVF depth, or physical signs of suspected
stenosis after careful palpation of the entire length of the
AVF. Most often, signs of maturation failure were com-
bined such as proximal AVF hammer pulse and palpable
distal AVF thickening or minimal AVF distention with
barely audible bruit. Duplex examination was selectively
used after these physical findings to assure patency.
Digital subtraction angiography was performed by the
primary author (R.B.M.) in a cardiovascular laboratory
with a 15-inch image intensifier if any of these physical
signs were detected. Technique generally included ante-
grade cannulation near the arterial anastomosis, com-
plete peripheral and central venous imaging, and arterial
anastomosis evaluation with mid-fistula compression.
Based on these results, endovascular and/or subsequent
operative procedures were performed if felt to be advan-
tageous to prevent failure and improve maturation. En-
dovascular interventions included percutaneous translu-
minal angioplasty for stenoses 50%. Flextome cutting
balloons (Boston Scientific, Boston, Mass) were used
routinely. Short occlusions (5 cm) were attempted to
be recanalized percutaneously. Procedures necessitating
operative intervention included such procedures as
branch ligation, revision with arm vein interposition,
vein patch angioplasty, and AVF superficialization.Following any intervention, subsequent follow-up
would continue every 6 to 8 weeks. Maturation was deter-
mined using physical examination by the vascular surgeon.
Criteria used to determine maturation included ease of
palpation, quality of thrill, usable length, and accommodat-
ing diameter. Upon concluding that these criteria were met
by physical examination, sequential needle transition was
begun. Generally, this sequence began with the arterial
needle (from the patient to the dialysis machine) and utili-
zation of venous flow through the tunneled dialysis cathe-
ter for 2 to 3 weeks followed by two needles for 2 to 3
weeks. Patients were then seen in the vascular clinic for
removal of tunneled dialysis catheter or evaluated if prob-
lems were occurring with needle transition. Depending on
the problem during needle transition, the AVF was either
rested or an angiogram was performed. AVFs that throm-
bosed during follow-up were abandoned and considered a
failure to mature.
Standard descriptive statistics are used for the data.
Statistical comparisons used t-test, chi square, and multi-
variate analysis. A P-value of .05 was considered signifi-
cant.
RESULTS
One hundred thirteen patients had 113 AVFs during
the 5-year period. During the same period, 74 arterio-
venous grafts were performed (61% first time AVF rate).
Mean age of the cohort was 64 years (range: 26-94) and
58% were male. Eighty percent of patients were Caucasian,
19% African-American, and 1% other. Risk factors and
comorbidities included 38 (33.6%) patients with a tobacco
history, 65 (57.5%) had diabetes mellitus, 92 (81.4%) had
hypertension, 50 (44.2%) had coronary artery disease, and
24 (21.2%) had peripheral arterial disease. Upper extremity
venous duplex mapping was performed in 109 (96.4%) of
patients. Distribution of AVFs included 8 (7%) radioce-
phalic, 90 (80%) brachiocephalic, and 15 (13%) basilic vein
transposition.
There were 83 (73%) patients not requiring interven-
tion and 30 (27%) requiring intervention prior to matura-
tion. Table I shows comparisons of demographics, risk
factors, and comorbidities between the two groups. Table
II shows the distribution of types of AVFs for those who did
and did not require intervention during follow-up. Patients
with AVFs not requiring intervention were significantly
more likely to be older, Caucasian, and have hypertension.
Patients with AVFs requiring intervention were signifi-
cantly more likely to be African-American. Multivariate
analysis revealed no significant demographic associations.
Interventions were not observed to be more necessary in
any type of AVF.
During the maturation process, there were nine
deaths and four transplants, leaving 100 patients requir-
ing maturation. No deaths were due to complications
secondary to a tunneled dialysis catheter. In patients not
requiring intervention, there were eight deaths and one
transplant while in those requiring intervention there
was one death and three transplants. Overall, including
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rate was 72% (failure rate of 28%). When patients that
died or had transplants were excluded, the maturation
rate was 82% (failure rate 18%). There was no significant
difference in failure rate between patients not requiring
intervention (13 of 83, 15%) and those requiring inter-
vention (5 of 30, 16%). None of the patients in the entire
cohort who died or had a renal transplant during the
maturation process thrombosed their AVF. Alternatively
stated, patients who died or went on to transplant during
the maturation process were noted to have a patent AVF
at last follow-up. No further follow-up was performed on
patients having transplant.
If the assumption that all AVFs in patients requiring
intervention would have failed if no interventions were
pursued, then the total failure rate would have been 38%
(nonintervention group failures [n 13] assumption [n
 30]  43). If patients who died or had transplant are
excluded, the failure rate increases to 43%. These percent-
ages were each significantly higher (P  .001) when com-
pared with the overall AVF failure rate from the compre-
hensive follow-up program (16% - entire cohort, 18% -
excluding deaths and transplants). If the assumption is
made that all failed group I AVFs (n  13) had an unde-
tected stenosis and those that matured were without a
stenosis (n 70), then our routine follow-up with physical
examination yielded a sensitivity of 70%, a specificity of
Table I. Comparisons of demographics, risk factors, and
comorbidities between group I (nonintervention) and
group II (intervention)
Group I
n  83 (%)
Group II
n  30 (%) P value
Age 66 (mean) 60 (mean) .02
Male 42 (51) 17 (56) .72
White 73 (88) 19 (64) .007
African-American 10 (12) 10 (32) .01
Smoker 29 (35) 10 (32) .99
Diabetes 49 (59) 16 (52) .74
HTN 72 (87) 20 (68) .03
CAD 36 (43) 14 (48) .92
PAD 17 (20) 6 (20) 1
Table II. Distribution of autogenous arteriovenous
hemodialysis access (AVFs) procedures for patients not
requiring intervention vs those that did require
intervention prior to maturation (No specific differences
were observed.)
AVFs with:
No intervention
(n  83)
Intervention
(n  30)
Radiocephalic 7 (8%) 1 (3%)
Brachiocephalic 64 (77%) 26 (87%)
Basilic vein
transposition 12 (14%) 3 (10%)100% and an accuracy of 88%.Of the 30 patients requiring intervention, 23 (61%) had
an endovascular intervention and 15 (39%) had an opera-
tive intervention. There was an average of 1.5 interventions
per patient with one intervention performed in 64%, two in
24%, and three in 12%. All endovascular interventions
consisted of percutaneous transluminal angioplasty. Oper-
ative interventions consisted of 12 requiring vein interpo-
sition or patch, one requiring superficialization, and two
requiring branch ligation. There were no differences in
distribution of interventions between AVF types. Ninety-
one percent of patients having an endovascular intervention
resulted in AVF maturation whereas 60% having operative
intervention resulted in maturation (P  .10). For those
patients needing maturation (excluding transplants prior to
maturation and deaths), patients requiring intervention
(mean: 35 weeks, range: 10-54) took significantly longer (P
 .003) than those not requiring intervention (mean 11
weeks, range: 6-35).
DISCUSSION
Routine postoperative physical examination at regular
intervals of newly placed AVFs as assessed by the operative
surgeon led to the detection of a significant number with
problems. All 30 (27%) patients that had angiography after
an abnormality was discovered on physical exam had a
procedure to increase the likelihood of maturation. Of
those, 25 went on to mature with use of two needles for at
least 30 days. Findings on physical exam that could indicate
a problem include: minimal increase in vein size in a person
with easily visualized veins; little or no thrill; barely audible
or high pitched bruit; the presence of a hammer pulse;
increasing predominance of branches emanating from the
AVF; increasing arm edema; signs of stenosis after careful
palpation of the AVF; problems with needle cannulation
due to AVF depth.
Although the reliability of physical examination can
be variable, this fact has to be weighed against the
variability that would occur given the predominant stan-
dard of one or no postoperative visits by the same
hemodialysis access surgeon following AVF creation.
Moreover, regular follow-up in hemodialysis units is
subject to changes in nurse staffing. Nevertheless, one
may assume that given poor maturation in a defined
number of patients, nephrologists and/or dialysis nurses
would obtain an angiogram to assess for problems in a
proportion of our cohort. The difference with more
rigorous follow-up is to heighten awareness and stan-
dardize the physical exam by the operating surgeon for
all patients to prevent thrombosis in those threatened
AVFs. Few AVFs can be salvaged after thrombosis prior
to maturation. It is the authors’ belief that AVFs with a
hammer pulse, minimal thrill, and high pitched bruit are
at most risk of thrombosis prior to maturation because
this constellation of findings is typically not regarded by
most physicians and allied health professionals involved
with hemodialysis as worrisome.
Consistent follow-up prior to maturation remains the
key to detection. In our study, this follow-up was provided
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follow-up, while waiting for maturation, becomes more
difficult in a busy dialysis unit with many allied health
professionals and other physicians (nephrologists, primary
care physicians, radiologists, and consultants) attending to
the patient. Additionally, surgeons who routinely perform
large numbers of AVFs are more likely to be better skilled in
assessing for lack of maturation from careful and meticu-
lous physical examination. These skills are transferable with
appropriate education and volume.
It must be emphasized that the skill of physical exam
by the vascular surgeon is far from perfect. There were
still 13 (12%) patients whereby physical examination did
not detect problems and the fistula did not reach matu-
ration. Our vascular laboratory does not perform routine
duplex surveillance of AVFs and henceforth, has not
performed a rigorous receiver-operator curve to deter-
mine the accuracy in detecting greater than 50% steno-
ses. The results of duplex for AVF and AV-graft surveil-
lance have been mixed. In a recent prospective
randomized trial of 186 patients with AV-grafts by Rob-
bin et al, duplex surveillance was no better than clinical
monitoring to enhance AV-graft patency.7 Although
angioplasty was performed significantly more often in
those AV-grafts having duplex surveillance, median time
to permanent graft failure did not differ between the two
groups (38 vs 37 months, P  .93). Similarly, Lumsden
et al. determined that AV-graft duplex surveillance did
not lead to improved patency.8 Little information is
published regarding duplex surveillance in AVFs. From a
small study in 1989, peak systolic Doppler frequency was
noted to have a sensitivity of 79%, a specificity of 84%,
and an accuracy of 81% in detecting greater than 50%
stenosis in 36 Brescia-Cimino AVFs.9 There are no clin-
ical reports documenting duplex surveillance in AVFs
that in the process of maturing. These duplex findings
may be different from duplex surveillance in the mature
AVF.
Given the reported range of AVF maturation failure
(25% to 43%), a more rigorous follow-up program may be
one area to prevent premature failure due to undetected
stenoses that could have been remedied by percutaneous or
operative intervention prior tomaturation.We recommend
that patients with AVFs return for a first postoperative visit
to the surgeon’s office in 3 to 6 weeks, and then, every 6 to
8 weeks thereafter to assess progression of fistula matura-
tion. The key issue to detecting problems by physical exam
is understanding the physical signs for potential problems
and consistency in having one person dedicated to reexam-
ining the patient. Theoretically, this could be implemented
in a dialysis unit by a trained allied health professional as
well. Certainly, even with an overall failure rate of 18% in
this study (less than many other published reports), routine
surveillance by angiography prior to presumed maturation
or needle access for all AVFs may be the best way currently
to assess for problems that could be developing after 30
days. With technical errors and poor patient/vein selection
yielding AVF failure in a majority of patients prior to 30days, a case for AVF surveillance using angiography prior to
cannulation may be warranted.
The lack of a control population in this study represents
a weakness. Nevertheless, the discovery of 30 AVFs need-
ing intervention prior to maturation speaks to the power of
a comprehensive follow-up program. K/DOQI recom-
mends a 3- to 4-month period to time for AVFs to mature
prior to cannulation.2 This interval may be misinterpreted
by nephrologists and surgeons that little assessment should
be done prior to that time. Our study has shown that 58%
of patients with a presumed lesion were identified and
treated with intervention. Most patients having interven-
tion (83%) matured their AVF. Information from this study
leads the authors to believe that lack of comprehensive
follow-up to assess fistula maturation will lead to increased
AVF failure and potentially even longer dependency on
tunneled dialysis catheters. Although those patients with
intervention had prolonged time to maturation in this
study, this time could be further worsened if AVF problems
are not identified sooner. Prospective trials are needed to
assess fistula maturation with different examination and
imaging techniques. Until then, K/DOQI should adopt
strict guidelines for a comprehensive follow-up program for
AVFs prior to maturation. Further consideration should be
made to recommend routine angiography prior to cannu-
lation of AVFs.
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